Pharmaceuticals
Moderna's Rally Is Not Over: Our Latest Trading Strategy
Thursday's rally was sparked by news that Moderna's Covid-19 vaccine candidate is moving to Phase II testing.
Here's What Would Resume the Bull Case for CVS
After CVS released quarterly earnings and the CEO's appearance on 'Mad Money,' let's look at the charts for this health and pharmacy retailer.
Here's How I'm Positioned and What I'm Holding
I see no reason to put much money into longer-term positions right now, but here are some of my biggest positions.
Regeneron Pharmaceuticals Could Trade Sideways Before Renewed Gains
Use available weakness to go long or add to longs.
The Charts of AbbVie Can Reach New Heights
A lifting on the moratorium on elective procedures could be a big win for ABBV.
CVS Health Reports and Here's How I'd Play It
CVS Health states that the chain has kept its stores open as an 'essential' retailer through this pandemic.
Here's a Quartet of Small Biotechs That Could Make for Acquisition Targets
Merger activity is picking up this week in the biotechnology sector and these four promising companies would be good buyout candidates.
Covering All Bases With Pfizer as It Aggressively Pursues a Covid-19 Vaccine
PFE is collaborating with German drugmaker BioNTech in the effort to find a well tolerated, effective vaccine.
CVS Must Be Taking Its Own Medicine: It's Looking Healthy
The charts of CVS are in good shape, so expect renewed strength in the weeks ahead.
Seattle Genetics Soars on Cancer Drugs: Here's How to Play the Stock
This biotech is on the front lines of oncology treatments.